MED Earnings Date: Feb 16, 2027 (Estimated) — Medifast, Inc.
NYSE · Consumer Discretionary · Personal Products & Services
Updated
When is MED's next earnings date?
Medifast, Inc. (MED) is expected to report Q4 2026 earnings on Tuesday, February 16, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13 on revenue of $63.3M.
How did MED do in its last earnings report?
In its most recent report on Oct 26, 2026 (Q3 2026), Medifast, Inc. posted EPS of -$0.19 versus the -$0.36 estimate, a beat of 47.2%. Revenue was $72.0M against a $70.6M estimate. The stock's 1-day post-earnings move was +3.1%.
How much does MED stock move after earnings?
MED beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.3% (up or down) in the day after earnings.
About Medifast, Inc.
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
🤖 AI Earnings Analysis
Medifast’s metabolic-health pivot has yet to arrest contraction: Q3 revenue fell 19% year over year to $72M, despite beating estimates by $1M. The $0.19-per-share loss beat by $0.17, but continued operating losses and a $270M–$300M revenue outlook make the turnaround unconvincing.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-26 | Q3 2026 | -0.36 | -0.19 | +47.22% | $72.0M | ✅ Beat | +3.14% | — | — |
| 2026-08-03 | Q2 2026 | -0.66 | -0.28 | +57.58% | $76.4M | ✅ Beat | +34.29% | +24.13% | +24.13% |
| 2026-05-04 | Q1 2026 | -0.53 | -0.19 | +64.15% | $76.0M | ✅ Beat | +22.48% | +16.65% | +15.15% |
| 2026-02-17 | Q4 2025 | -0.80 | -0.55 | +31.25% | $75.1M | ✅ Beat | -0.83% | -2.96% | -6.48% |
| 2025-11-03 | Q3 2025 | -0.22 | -0.21 | +4.55% | $89.4M | ✅ Beat | +0.84% | -0.76% | -7.32% |
| 2025-04-28 | Q1 2025 | -0.25 | -0.07 | +72.00% | $115.7M | ✅ Beat | -0.64% | +4.13% | +7.15% |
| 2025-02-18 | Q4 2024 | -0.16 | 0.10 | +162.50% | $119.0M | ✅ Beat | -11.41% | -10.79% | -12.34% |
| 2024-11-04 | Q3 2024 | -0.28 | 0.35 | +225.00% | $140.2M | ✅ Beat | +8.45% | +3.30% | +4.94% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q4 FY17 · $78.0M total
| Segment | Share | Revenue | YoY | Q2 FY16 | Q3 FY16 | Q4 FY16 | Q1 FY17 |
|---|---|---|---|---|---|---|---|
| Optavia | 88.0% | $68.6M | — | — | — | — | — |
| Medifast Direct | 8.4% | $6.6M | -3.0% | $9.3M | $8.1M | $6.8M | $8.9M |
| Franchise Weight Control Centers | 3.3% | $2.6M | -28.4% | $4.1M | $3.7M | $3.6M | $3.5M |
| Medifast Wholesale Physicans | 0.3% | $218K | -12.1% | $300K | $273K | $248K | $261K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.